#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Scleroderma associated digital ulcer Autoimmune haemolytic anaemia Diffuse large B-cell lymphoma recurrent Transitional cell cancer of the renal pelvis and ureter Idiopathic pulmonary fibrosis Hypergammaglobulinaemia benign monoclonal Cardiac amyloidosis Mitochondrial encephalomyopathy Thrombotic thrombocytopenic purpura Epilepsy with myoclonic-atonic seizures Pleural mesothelioma malignant Urea cycle disorder Angiosarcoma recurrent T-cell lymphoma Cardiac sarcoidosis More trials…

    Learn about Rare Diseases

    Loeys-Dietz syndrome – Basic Information Urea cycle disorder – Basic Information Medulloblastoma Mantle cell lymphoma refractory Langerhans’ cell histiocytosis – Diagnostics Turner’s syndrome – Trials in Disease Cholangitis sclerosing – Life with Disease Tuberous sclerosis complex Bronchiolitis obliterans syndrome – Treatment Glycogen storage disease type I – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Clomipramine Hydrochloride Cx-037231 Lisinopril Dihydrate Dosulepin Hydrochloride RO7795081 Clobetasol Perampanel Loncastuximab Tesirine Caffeine Citrate Bp1.7881A Vibostolimab Valproic Acid Isoprenaline Hydrochloride Amikacin Sulfate Obinutuzumab Cefalexin Monohydrate Taurine Indometacin Bt8009 Calcium Folinate Pentahydrate More therapies…

    Learn about Your Condition

    Ectopic pregnancy Mucopolysaccharidosis II Pancreatic carcinoma Arginase deficiency Bronchiolitis Hip fracture EGFR gene mutation Intellectual disability Eye disorder Loeys-Dietz syndrome Astrocytoma malignant Pancreatic neoplasm Aphthous ulcer Retinopathy of prematurity Bacterial vaginosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Follicular lymphoma

  • Study on Mosunetuzumab and Lenalidomide for Patients with Untreated Follicular Lymphoma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Mosunetuzumab
    • Bendamustine Hydrochloride
    • Cyclophosphamide
    Austria Belgium France Germany Portugal Spain

  • Study on Radiotherapy Alone or with Obinutuzumab for Patients with Early Stage Follicular Lymphoma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Obinutuzumab
    Italy

  • Study of AZD0486 plus rituximab versus standard chemotherapy drug combination in previously untreated follicular lymphoma patients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Follicular lymphoma
    Investigated Drugs:
    • Bendamustine Hydrochloride
    • Human Igg4 Kappa Monoclonal Antibody Against Cd3 And Cd19
    • Cyclophosphamide
    Denmark

  • Study of Loncastuximab Tesirine and Epcoritamab for Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma, High-grade B-cell Lymphoma, or Follicular Lymphoma Grade 3B

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • High-grade B-cell lymphoma
    • Follicular lymphoma
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Loncastuximab Tesirine
    • Epcoritamab
    Germany

  • Study on Mosunetuzumab and Lenalidomide for Untreated Follicular Lymphoma Patients

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Follicular lymphoma
    Investigated Drugs:
    • Mosunetuzumab
    Belgium

  • Evaluation of Safety and Efficacy of Zilovertamab Vedotin and Nemtabrutinib in Aggressive and Indolent B-cell Malignancies

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Nemtabrutinib
    • Zilovertamab Vedotin
    Czechia Estonia Germany Ireland Italy Poland +3
Previous Page
1 2 3 4 5 … 7
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!